NEW YORK CITY, NY / ACCESS Newswire / January 22, 2026 / Emerging Growth Research today released a Flash Research ...
Antibodies Inc., a leading supplier of validated life science research reagents, today announced the availability of its Recombinant Guinea Pig RBPMS Antibody (Clone OTI3B7-GP, Cat. No. 1834-RBPMS)—a ...
The "Cancer Antibody Drug Conjugates Global Market Report 2025" has been added to ResearchAndMarkets.com's offering.The ...
Fabentech, a French biopharmaceutical company specializing in medical countermeasures against biological threats, today ...
The global cancer monoclonal antibodies market size is expected to reach over USD 577.26 billion by 2034, increasing from USD 125.10 billion in 2025 and it is representing a double-digit compound ...
Bispecific antibodies represent an important innovation in the field of biomedicine in recent years. Compared to monoclonal antibodies, their specific structure enables a single antibody molecule to ...
Therapeutic antibodies, especially polyclonal antibodies, are indispensable in contemporary medicine for addressing a broad spectrum of conditions, including infectious diseases, autoimmune disorders, ...
The paper addresses the problem of optimising the mapping of serum antibody responses against a known antigen. The manuscript describes a method using EM polyclonal epitope mapping to help elucidate ...
Copyright: © 2025 The Author(s). Published by Elsevier B.V. Lassa fever, caused by Lassa virus, is a severe disease, endemic in Western Africa, for which no vaccines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results